Evidence map›Paper›PMID 37029886›Full record

ReviewMagma (New York, N.Y.)2023

Germany's journey toward 14 Tesla human magnetic resonance.

Mark E Ladd, Harald H Quick, Oliver Speck, Michael Bock, Arnd Doerfler, Michael Forsting, Jürgen Hennig, Bernd Ittermann, Harald E Möller, Armin M Nagel and 14 more

Abstract readReview
In one paragraph

Review in Magma (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Metamaterial Antennas Enhance MRI of the Eye and Occipital Brain.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  3. Preoperative Imaging for Cochlear Implantation: A Global Consensus.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Article
  4. Review
  5. Multi-center QA of ultrahigh-field systems.Magma (New York, N.Y.) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Mark E Ladd *Medical Physics in Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. mark.ladd@dkfz.de.ORCID http://orcid.org/0000-0002-4128-9440
Harald H Quick *Erwin L. Hahn Institute for MRI, University of Duisburg-Essen, Essen, Germany.
Oliver Speck *Department of Biomedical Magnetic Resonance, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Michael BockDivision of Medical Physics, Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Arnd DoerflerDepartment of Neuroradiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
Michael ForstingInstitute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
Jürgen HennigDivision of Medical Physics, Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Bernd IttermannMedical Physics and Metrological Information Technology, Physikalisch-Technische Bundesanstalt (PTB), Berlin, Germany.
Harald E MöllerMethods and Development Group Nuclear Magnetic Resonance, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Armin M NagelMedical Physics in Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Thoralf NiendorfBerlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Stefan RemyGerman Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Tobias SchaeffterMedical Physics and Metrological Information Technology, Physikalisch-Technische Bundesanstalt (PTB), Berlin, Germany.
Klaus SchefflerMagnetic Resonance Center, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
Heinz-Peter SchlemmerRadiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Sebastian SchmitterMedical Physics and Metrological Information Technology, Physikalisch-Technische Bundesanstalt (PTB), Berlin, Germany.
Laura SchreiberDepartment of Cardiovascular Imaging, Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany.
N Jon ShahInstitute of Neuroscience and Medicine - 4, Forschungszentrum Jülich, Jülich, Germany.
Tony StöckerMR Physics, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Michael UderInstitute of Radiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
Arno VillringerDepartment of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Nikolaus WeiskopfDepartment of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Moritz ZaissDepartment of Neuroradiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
Maxim ZaitsevDivision of Medical Physics, Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple sites within Germany operate human MRI systems with magnetic fields either at 7 Tesla or 9.4 Tesla. In 2013, these sites formed a network to facilitate and harmonize the research being conducted at the different sites and make this technology available to a larger community of researchers and clinicians not only within Germany, but also worldwide. The German Ultrahigh Field Imaging (GUFI) network has defined a strategic goal to establish a 14 Tesla whole-body human MRI system as a national research resource in Germany as the next progression in magnetic field strength. This paper summarizes the history of this initiative, the current status, the motivation for pursuing MR imaging and spectroscopy at such a high magnetic field strength, and the technical and funding challenges involved. It focuses on the scientific and science policy process from the perspective in Germany, and is not intended to be a comprehensive systematic review of the benefits and technical challenges of higher field strengths.

Indexed as

Magnetic Resonance ImagingWhole Body ImagingGermanyHumansMagnetic FieldsMagnetic Resonance Spectroscopy14TExtremely high fieldGUFIMRIUltrahigh field

Identifiers

PMID37029886
PMCPMC10140098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.